Related Experiment Videos
Increased expression and function of glutamate transporters in multiple sclerosis
Ainara Vallejo-Illarramendi1, María Domercq, Fernando Pérez-Cerdá
1Departamento de Neurociencias, Universidad del País Vasco, E-48940, Leioa, Vizcaya, Spain.
Neurobiology of Disease
|August 3, 2005
Summary
In multiple sclerosis (MS), increased glutamate transporters (EAAT1 and EAAT2) in optic nerves help clear toxic glutamate levels. This suggests a protective response by glial cells during CNS inflammation and neurodegeneration.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Glutamate excitotoxicity is implicated in multiple sclerosis (MS) pathogenesis.
- Glutamate transporters regulate extracellular glutamate levels, preventing excitotoxicity.
- Understanding transporter function in MS is crucial for therapeutic development.
Purpose of the Study:
- To investigate the expression and function of glutamate transporters (EAAT1, EAAT2, EAAT3) in multiple sclerosis optic nerve samples.
- To determine if glutamate transporter levels change during MS and if these changes correlate with excitotoxicity.
Main Methods:
- Analysis of glutamate transporter mRNA and protein expression (EAAT1, EAAT2, EAAT3) in human control and MS optic nerve samples.
- Functional assays to measure glutamate uptake capacity in MS and control samples.
- Experimental induction of glutamate transporter changes in rat optic nerves using excitotoxic glutamate.
Main Results:
- Elevated levels of glutamate transporters EAAT1 and EAAT2 mRNA and protein were observed in MS optic nerves compared to controls.
- Functional assays revealed increased glutamate uptake in MS samples.
- Excitotoxic glutamate treatment in rat optic nerves mimicked the observed increases in glutamate transporters.
Conclusions:
- Enhanced expression of glutamate transporters EAAT1 and EAAT2 in MS optic nerves represents a compensatory mechanism.
- Glial cells upregulate glutamate transporters in response to elevated glutamate levels during CNS inflammation and neurodegeneration in MS.
- These findings highlight a potential therapeutic target for managing glutamate excitotoxicity in multiple sclerosis.